Alpha Teknova Insider Grant: 138k Options Vesting Over 4 Years

Rhea-AI Filing Summary

Alpha Teknova, Inc. (TKNO) filed a Form 4 on 25 June 2025 detailing an equity-based compensation award to its General Counsel & Chief Compliance Officer, Damon A. Terrill. The filing reports a single grant of non-qualified stock options covering 137,808 common shares.

The option was granted on 14 February 2025 with an exercise price of $8.28 per share and a ten-year term expiring on 14 February 2035. The award vests in 48 equal monthly installments beginning one month after the grant date, aligning Mr. Terrill’s incentives with longer-term shareholder value creation. There were no open-market purchases or sales of TKNO common stock disclosed, and Mr. Terrill’s post-transaction beneficial ownership consists solely of the 137,808 derivative securities reported.

Because the transaction involves only the issuance of options rather than immediate share issuance, it has no direct impact on current share count or cash flows. However, full exercise would add up to 137,808 new shares to the outstanding share base, representing modest potential dilution. Overall, the disclosure appears to be a routine insider compensation event rather than a signal of changing fundamentals or insider sentiment.

Positive

• Incentive alignment: Monthly vesting over four years encourages long-term commitment from a key executive.

Negative

• Potential dilution: Exercise of 137,808 options could modestly increase share count.

Insights

Corporate Governance Analyst

TL;DR: Routine option grant; minor potential dilution; neutral investment impact.

The Form 4 reveals a standard non-qualified option grant to Damon Terrill, Alpha Teknova’s General Counsel and CCO. The 137,808-share award vests monthly over four years, an incentive structure commonly used to retain key executives and align their interests with shareholders. At an $8.28 strike price and a 10-year life, the options create upside participation without immediate balance-sheet consequences, leaving current EPS and cash unchanged.

The potential dilution—roughly 138 k shares—appears immaterial absent broader context on TKNO’s total shares outstanding, but on its face it is not large enough to move valuation multiples. No shares were sold or purchased, so there is no insider sentiment signal. Given the routine nature and limited size, I view the market impact as neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Terrill Damon

(Last) (First) (Middle)

C/O ALPHA TEKNOVA, INC.

2451 BERT DRIVE

(Street)

HOLLISTER CA 95023

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alpha Teknova, Inc. [ TKNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel and CCO

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$8.28	02/14/2025		A		137,808		(1)	02/14/2035	Common Stock	137,808	$0.0	137,808	D

Explanation of Responses:

1. The number of shares subject to the option shall vest in 48 equal monthly installments on the same day of each month after February 14, 2025, the date of grant.

	Damon A. Terrill	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Alpha Teknova (TKNO) report in its latest Form 4?

The filing discloses a grant of 137,808 non-qualified stock options to General Counsel & CCO Damon A. Terrill.

How many TKNO shares are covered by the new option grant?

The option covers 137,808 shares of Alpha Teknova common stock.

What is the exercise price and expiration date of the options?

The options have a $8.28 exercise price and expire on 14 February 2035.

How does the vesting schedule work for this option grant?

The award vests in 48 equal monthly installments beginning one month after 14 February 2025.

Did the filing report any insider sale or purchase of TKNO common stock?

No. The Form 4 shows only the option grant; no shares were bought or sold.

When was the transaction and when was the Form 4 filed?

The transaction date is 14 February 2025; the Form 4 was filed on 25 June 2025.